Capital International, Inc./CA/
Source: SEC Form 13F · as of Mar 2026Capital International, Inc./CA/ holds 28 biotech & pharma companies tracked by BioSniper, totaling $1.73B in value as of Mar 2026 (SEC Form 13F).
| Company | Shares | Value |
|---|
| AZNASTRAZENECA PLC | 2,009,997 | $392.7M |
| PMPhilip Morris International Inc | 1,914,057 | $316.5M |
| LLYELI LILLY & Co | 193,029 | $177.5M |
| AMGNAMGEN INC | 398,069 | $140.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 392,075 | $106.1M |
| ABTABBOTT LABORATORIES | 933,491 | $95.8M |
| ABBVAbbVie Inc. | 430,429 | $93.6M |
| ONCBeOne Medicines Ltd. | 302,243 | $89.8M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 161,723 | $72.2M |
| GILDGILEAD SCIENCES, INC. | 355,956 | $49.6M |
| RPRXRoyalty Pharma plc | 1,023,880 | $49.1M |
| JNJJOHNSON & JOHNSON | 156,815 | $38.3M |
| QGENQIAGEN N.V. | 449,833 | $18.0M |
| ZBHZimmer Biomet Holdings Inc. | 167,717 | $15.2M |
| GMOptec International, Inc. | 154,345 | $11.5M |
| PFEPFIZER INC | 374,286 | $10.5M |
| REGNREGENERON PHARMACEUTICALS, INC. | 11,759 | $9.1M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 25,550 | $8.5M |
| IDXXIDEXX LABORATORIES INC /DE | 13,507 | $7.6M |
| ELVElevance Health Inc. | 20,557 | $6.0M |
| NVONovo Nordisk A/S | 155,415 | $5.7M |
| BMYBRISTOL MYERS SQUIBB CO | 92,292 | $5.6M |
| MCKMcKesson Corporation | 5,277 | $4.6M |
| CAHCardinal Health Inc. | 14,843 | $3.1M |
| CRSPCRISPR Therapeutics AG | 34,340 | $1.6M |
| GRFSGrifols S.A. | 190,360 | $1.5M |
| ICLRICON plc | 13,663 | $1.5M |
| MRKMerck & Co., Inc. | 6,008 | $723K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.